Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 19, 2003
Inflammatory processes in Alzheimer's diseaseEdith G McGeer, Patrick L McGeerJournal of Alzheimer'S Disease : JAD|January 12, 2010
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancyEdith G McGeer, Patrick L McGeerExpert Opinion on Investigational Drugs|July 2, 2003
Clinically tested drugs for Alzheimer's diseaseEdith G McGeer, Patrick L McGeerExpert Opinion on Therapeutic Targets|December 2, 2014
Targeting microglia for the treatment of Alzheimer's diseasePatrick L McGeer, Edith G McGeerParkinsonism & Related Disorders|April 28, 2004
Inflammation and neurodegeneration in Parkinson's diseasePatrick L McGeer, Edith G McGeerMovement Disorders : Official Journal of the Movement Disorder Society|November 30, 2007
Glial reactions in Parkinson's diseasePatrick L McGeer, Edith G McGeerExperimental Gerontology|June 28, 2002
Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaquesPatrick L McGeer, Edith G McGeer, Koji YasojimaCurrent Opinion in Neurology|May 15, 2007
Therapeutic approaches to inflammation in neurodegenerative diseaseAndis Klegeris, Edith G McGeer, Patrick L McGeerNeurobiology of Aging|January 21, 2017
A review of human diseases caused or exacerbated by aberrant complement activationPatrick L McGeer, Moonhee Lee, Edith G McGeerNeurobiology of Aging|August 2, 2016
Quercetin, not caffeine, is a major neuroprotective component in coffeeMoonhee Lee, Edith G McGeer, Patrick L McGeerPageof 5